(571) 447-5500

EAS Blog

EAS Independent Consultants and staff provide in-depth regulatory expertise and authoritative reporting on a variety of compliance requirements for industries that EAS serves. Our experts break down complicated topics into easily understandable summaries and analysis. Subscribe to our newsletter and receive these monthly updates directly in your in-box.

Drug and Device Corner July 2025

Drug and Device Corner July 2025

The FDA issued a notification on 9 July 2025 regarding an FDA Imports Review Exemption Change. The agency has rescinded the FDA review exemption that had previously been applicable to importation of certain low-value FDA regulated products. Henceforth all FDA regulated products will be reviewed...

read more
FDA to Revoke 52 Obsolete Standards of Identity for Food Products

FDA to Revoke 52 Obsolete Standards of Identity for Food Products

July 16, 2025 View on FDA WebsiteThe U.S. Food and Drug Administration today announced it is revoking, or proposing to revoke, 52 food standards after concluding they are obsolete and unnecessary. The 52 standards are for canned fruits and vegetables, dairy products, baked goods, macaroni products...

read more

cGMP Responsibilities for Own Label Distributors and Brand Owners

cGMP Responsibilities for Own Label Distributors and Brand OwnersPresented by Shelly BlackwellDecember 18, 2025, 1pm (eastern)Own Label Distributors (OLD) in the dietary supplement industry often question their responsibilities for complying with current Good Manufacturing Practices (cGMP’s)...

read more
Conducting Remote Regulatory Assessments Questions and Answers

Conducting Remote Regulatory Assessments Questions and Answers

Docket Number: FDA-2022-D-0810 Issued by: Office of Inspections and Investigations Center for Biologics Evaluation and Research Center for Devices and Radiological Health Center for Drug Evaluation and Research Center for Tobacco Products Center for Veterinary Medicine Human Foods Program Office...

read more
Foods Program FDA Guidance Under Development

Foods Program FDA Guidance Under Development

The following list of guidance topics includes possible new topics for guidance documents or revisions to existing guidance documents that the FDA is considering for Human and Animal Foods. The lists below include some of the guidance documents under consideration to be developed. That said,...

read more
FDA Updates General Food Labeling Requirements Compliance Program

FDA Updates General Food Labeling Requirements Compliance Program

Constituent Updates June 24, 2025 Read on FDA Website The U.S. Food and Drug Administration has updated Compliance Program 7321.005, now titled General Food Labeling Requirements and Labeling-Related Sample Analysis – Domestic and Import. This update replaces the previous 2010 version of the...

read more
Drug and Device Corner June 2025

Drug and Device Corner June 2025

The FDA has released two proposed administrative orders for requesting minor dosage form changes to certain OTC monograph drugs. These administrative orders are open for comment. Proposed Administrative Order OTC000038 If finalized, this proposed order will specify requirements for industry to...

read more
Raising Your Nutrition Label IQ

Raising Your Nutrition Label IQ

Many people have difficulty understanding the Nutrition Facts label, especially with regards to properly interpreting and using the information about serving sizes and the percent Daily Values. This webinar will clear up some of the confusion about these and other labeling issues. This webinar will also discuss some of the science that went into developing the Nutrition Facts label and explain why FDA decided to update and modernize the label in 2016. By attending this webinar, you will become a more knowledgeable label reader.

read more
Drug and Device Corner May 2025

Drug and Device Corner May 2025

Reminder that OMUFA FY2025 facility user fees are due Monday 2 June 2025. MDF fee is $37,556; CMO fee is $25,037. Please see the FDA website for full details. Do note below the agency will be providing an OMUFA user fee and registration webinar Tuesday 20 May 2025.FDA Announces Expanded Use of...

read more
Dietary Component Specifications and Testing

Dietary Component Specifications and Testing

Since the FDA’s dietary supplement cGMP regulations (21 CFR Part 111) were published, specifications and testing have been consistently one of the most frequently cited FDA observations. Specifically, industry continues to face challenges in complying with the specification and testing requirements for dietary supplement components.

read more
FDA Approves Three Food Colors from Natural Sources

FDA Approves Three Food Colors from Natural Sources

May 09, 2025The U.S. Food and Drug Administration announced it granted three new color additive petitions that will expand the palette of available colors from natural sources for manufacturers to safely use in food. The FDA is in line with U.S. Department of Health and Human Services Secretary...

read more
Front-of-Package Nutrition Information; Extension of Comment Period

Front-of-Package Nutrition Information; Extension of Comment Period

In response to requests for an extension, the FDA is extending the comment period for the proposed rule entitled ‘‘Food Labeling: Front-of-Package Nutrition Information’’ that appeared in the Federal Register of January 16, 2025, by 60 days. Either electronic or written comments must be submitted...

read more
Animal Feed Regulatory Pathways

Animal Feed Regulatory Pathways

By Adam Orr, EAS Consulting Group Independent ConsultantAs you know, food is regulated by the FDA under the Federal Food Drug and Cosmetic Act (FDCA). In brief, it defines food as articles used for food or drink for man or other animals and defines food additives as any substance which may result,...

read more
Drug and Device Corner April 2025

Drug and Device Corner April 2025

Under GDUFA, human generic drug facilities, sites, and organizations are required to submit identification information electronically to FDA annually. These submissions are made during the month of May The following types of generic industry facilities, sites, and organizations are required to...

read more
In Memoriam: Bruce Elsner

In Memoriam: Bruce Elsner

We have sad news to share on the passing of Bruce Elsner who was a long-time member of the EAS family and consulting team. Bruce had over 28 years of experience working in FDA regulated Fortune 500 companies, who manufactured and packaged drug, medical device, and cosmetic products. His...

read more
EAS Consulting Group Expands Expertise with the Addition of Two Former FDA Staffers

EAS Consulting Group Expands Expertise with the Addition of Two Former FDA Staffers

EAS Consulting Group is pleased to announce the addition of two highly accomplished former FDA staff members, Gabriel Muñiz and Adam Orr, to its team of independent consultants. Their expertise in regulatory compliance and experience in the FDA’s tobacco and animal feed sectors will further strengthen EAS’s ability to provide superior guidance to clients navigating complex regulatory landscapes.

read more
Drug and Device Constituent Update 2025 April

Drug and Device Constituent Update 2025 April

We want to keep our clients up to date as we learn of any changes at the FDA that will affect normal business processes. The following 3 points have come to our attention in the last few days. For any questions regarding the status of a product in the NDC Directory, you may access downloadable NDC...

read more